Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indol

EU orphan designation number: EU/3/07/487   
Active ingredient: 4-ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indol
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: BlackSwan Pharma GmbH
Deutscher Platz 5e, D-04103 Leipzig, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/11/2007 Centralised Orphan - Designation EMEA/OD/057/07 (2007)5573 of 14/11/2007
20/01/2009 Other procedure
15/09/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/057/07/T/01 (2009)7040 of 14/09/2009